Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Tianyin Pharma Reports Higher Revenues and Costs

publication date: Nov 11, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Tianyin Pharmaceutical Co. reported higher results for the first quarter of 2009 fiscal year. Revenues rose 33 % to $9.6 million, while net income increased at a slower pace, rising 11% to $1.8 million. However, because the number of shares outstanding almost doubled to 24.6 million shares, earnings per share dropped to 7 cents in Q1 from 12 cents a year ago. More details...
Stock Symbol: (AMEX: TPI)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...